Sophia Genetics Shares Jump 8.7% Following $50M Stock Offering Pricing
SOPH has more than doubled off its 52-week low of $2.59 on elevated volume (7.1× avg).
Summary
SOPHiA GENETICS shares advanced 8.7% after the company priced its $50 million public offering of 10.5 million ordinary shares at $4.75 per share. This follows the announcement and pricing of the offering earlier today. The positive market reaction to a dilutive capital raise is noteworthy, indicating investor confidence in the company's use of funds or its overall outlook. The offering is expected to close on June 18.
At the time of this announcement, SOPH was trading at $5.37 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $384.9M. The 52-week trading range was $2.59 to $5.70. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.